KAYLA MORANO: Open Payments
NPI 1669949350 · BILOXI, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,394 in 53 payments from 14 companies in 2025. Trend: 2023 $725 · 2024 $998 · 2025 $1,394
Food & beverage: $1,394
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 16 | $343 |
| Edwards Lifesciences Corporation | 2 | $279 |
| Abbott Laboratories | 5 | $119 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $112 |
| Merck Sharp & Dohme LLC | 4 | $98 |
| ABIOMED | 3 | $88 |
| Baxter Healthcare | 2 | $81 |
| PFIZER INC. | 3 | $65 |
| Amgen Inc. | 4 | $64 |
| SCPHARMACEUTICALS INC. | 2 | $45 |
Products named: CAMZYOS, PASCAL, Kerendia, Hillrom - Carnation Ambulatory Monitor, ESPRIT, VERQUVO, VYNDAQEL, REPATHA.
Industry payments across MS — which companies pay providers there.
